These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 32936290)
121. lncRNA WT1-AS inhibits the aggressiveness of cervical cancer cell via regulating p53 expression via sponging miR-330-5p. Cui L; Nai M; Zhang K; Li L; Li R Cancer Manag Res; 2019; 11():651-667. PubMed ID: 30666161 [TBL] [Abstract][Full Text] [Related]
122. LncRNA SNHG14 promotes the progression of cervical cancer by regulating miR-206/YWHAZ. Ji N; Wang Y; Bao G; Yan J; Ji S Pathol Res Pract; 2019 Apr; 215(4):668-675. PubMed ID: 30611620 [TBL] [Abstract][Full Text] [Related]
123. Prognostic Value of Long Noncoding RNAs in Patients with Gastrointestinal Cancer: A Systematic Review and Meta-Analysis. Kang W; Zheng Q; Lei J; Chen C; Yu C Dis Markers; 2018; 2018():5340894. PubMed ID: 30598708 [TBL] [Abstract][Full Text] [Related]
124. Diagnostic Value of lncRNAs as Biomarker in Hepatocellular Carcinoma: An Updated Meta-Analysis. Chen S; Zhang Y; Wu X; Zhang C; Li G Can J Gastroenterol Hepatol; 2018; 2018():8410195. PubMed ID: 30410873 [TBL] [Abstract][Full Text] [Related]
125. LncRNA DANCR promotes cervical cancer progression by upregulating ROCK1 via sponging miR-335-5p. Liang H; Zhang C; Guan H; Liu J; Cui Y J Cell Physiol; 2019 May; 234(5):7266-7278. PubMed ID: 30362591 [TBL] [Abstract][Full Text] [Related]
126. LncRNA MNX1-AS1 promotes the progression of cervical cancer through activating MAPK pathway. Liu X; Yang Q; Yan J; Zhang X; Zheng M J Cell Biochem; 2019 Mar; 120(3):4268-4277. PubMed ID: 30302806 [TBL] [Abstract][Full Text] [Related]
127. An expression signature model to predict lung adenocarcinoma-specific survival. Shi X; Tan H; Le X; Xian H; Li X; Huang K; Luo VY; Liu Y; Wu Z; Mo H; Chen AM; Liang Y; Zhang J Cancer Manag Res; 2018; 10():3717-3732. PubMed ID: 30288103 [TBL] [Abstract][Full Text] [Related]
128. Systematic analysis of lncRNA-miRNA-mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer. Fan CN; Ma L; Liu N J Transl Med; 2018 Sep; 16(1):264. PubMed ID: 30261893 [TBL] [Abstract][Full Text] [Related]
129. Exploring the mechanisms behind long noncoding RNAs and cancer. Balas MM; Johnson AM Noncoding RNA Res; 2018 Sep; 3(3):108-117. PubMed ID: 30175284 [TBL] [Abstract][Full Text] [Related]
130. Emerging roles of long non-coding RNAs in tumor metabolism. Sun H; Huang Z; Sheng W; Xu MD J Hematol Oncol; 2018 Aug; 11(1):106. PubMed ID: 30134946 [TBL] [Abstract][Full Text] [Related]
131. Long noncoding RNAs in cervical cancer. Shi D; Zhang C; Liu X J Cancer Res Ther; 2018; 14(4):745-753. PubMed ID: 29970647 [TBL] [Abstract][Full Text] [Related]
132. Emerging roles of long non-coding RNA in cancer. Sanchez Calle A; Kawamura Y; Yamamoto Y; Takeshita F; Ochiya T Cancer Sci; 2018 Jul; 109(7):2093-2100. PubMed ID: 29774630 [TBL] [Abstract][Full Text] [Related]
133. Reconstruction and analysis of the aberrant lncRNA-miRNA-mRNA network based on competitive endogenous RNA in CESC. Song J; Ye A; Jiang E; Yin X; Chen Z; Bai G; Zhou Y; Liu J J Cell Biochem; 2018 Aug; 119(8):6665-6673. PubMed ID: 29741786 [TBL] [Abstract][Full Text] [Related]
134. Differentially expressed mRNAs, lncRNAs, and miRNAs with associated co-expression and ceRNA networks in ankylosing spondylitis. Zhang C; Wang C; Jia Z; Tong W; Liu D; He C; Huang X; Xu W Oncotarget; 2017 Dec; 8(69):113543-113557. PubMed ID: 29371928 [TBL] [Abstract][Full Text] [Related]
135. Cancer statistics, 2018. Siegel RL; Miller KD; Jemal A CA Cancer J Clin; 2018 Jan; 68(1):7-30. PubMed ID: 29313949 [TBL] [Abstract][Full Text] [Related]
136. Long Noncoding RNA in Cancer: Wiring Signaling Circuitry. Lin C; Yang L Trends Cell Biol; 2018 Apr; 28(4):287-301. PubMed ID: 29274663 [TBL] [Abstract][Full Text] [Related]
137. Pan-cancer transcriptomic analysis associates long non-coding RNAs with key mutational driver events. Ashouri A; Sayin VI; Van den Eynden J; Singh SX; Papagiannakopoulos T; Larsson E Nat Commun; 2016 Oct; 7():13197. PubMed ID: 28959951 [TBL] [Abstract][Full Text] [Related]
138. Integrative miRNA analysis identifies hsa-miR-3154, hsa-miR-7-3, and hsa-miR-600 as potential prognostic biomarker for cervical cancer. Zeng Y; Wang KX; Xu H; Hong Y J Cell Biochem; 2018 Feb; 119(2):1558-1566. PubMed ID: 28771797 [TBL] [Abstract][Full Text] [Related]
139. Development of a novel prognostic signature of long non-coding RNAs in lung adenocarcinoma. Zheng S; Zheng D; Dong C; Jiang J; Xie J; Sun Y; Chen H J Cancer Res Clin Oncol; 2017 Sep; 143(9):1649-1657. PubMed ID: 28409273 [TBL] [Abstract][Full Text] [Related]
140. Use of Mature miRNA Strand Selection in miRNAs Families in Cervical Cancer Development. Granados-López AJ; Ruiz-Carrillo JL; Servín-González LS; Martínez-Rodríguez JL; Reyes-Estrada CA; Gutiérrez-Hernández R; López JA Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28216603 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]